Evidence map›Paper›PMID 39468843›Full record

ArticleClinical and molecular hepatology2025

Prevalence of steatotic liver disease and associated fibrosis in the general population: An epidemiological survey: Letter to the editor on "Epidemiology of metabolic dysfunction-associated steatotic liver disease".

Lin Guan, Xinhe Zhang, Shanghao Liu, Xiaolong Qi, Yiling Li

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and molecular hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lin GuanDepartment of Gastroenterology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Xinhe ZhangDepartment of Gastroenterology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Shanghao LiuCenter of Portal Hypertension, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology (Southeast University), Nanjing, China.
Xiaolong QiCenter of Portal Hypertension, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology (Southeast University), Nanjing, China.
Yiling LiDepartment of Gastroenterology, The First Hospital of China Medical University, Shenyang, Liaoning, China.

Funding

Scientific Research Fund of Liaoning Provincial Education Department JYTMS20230082Scientific Research Fund of Liaoning Provincial Education Department LJKMZ20221167
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Advanced fibrosisPrevalenceSteatotic liver disease

Identifiers

PMID39468843
PMCPMC12016584

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.